Pub. Date : 2001
PMID : 11521725
3 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
1 | Another phase II study of trastuzumab plus paclitaxel, both given weekly, in 63 HER2-positive and -negative patients with metastatic breast cancer produced an overall response rate of 62% in HER2-positive and 44% in HER2-negative patients. | Paclitaxel | erb-b2 receptor tyrosine kinase 2 | Homo sapiens |
2 | Another phase II study of trastuzumab plus paclitaxel, both given weekly, in 63 HER2-positive and -negative patients with metastatic breast cancer produced an overall response rate of 62% in HER2-positive and 44% in HER2-negative patients. | Paclitaxel | erb-b2 receptor tyrosine kinase 2 | Homo sapiens |
3 | Another phase II study of trastuzumab plus paclitaxel, both given weekly, in 63 HER2-positive and -negative patients with metastatic breast cancer produced an overall response rate of 62% in HER2-positive and 44% in HER2-negative patients. | Paclitaxel | erb-b2 receptor tyrosine kinase 2 | Homo sapiens |